Register for our free email digests:
Division of Takeda Pharmaceutical Co. Ltd.
Latest From MidaSol Therapeutics LP
The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.
- Therapeutic Areas
- Immune Disorders
- North America
- Parent & Subsidiaries
- Takeda Pharmaceutical Co. Ltd.
- Senior Management
Troy Wilson, PhD, Pres. & CEO
Christian Rommel, PhD, CSO
Heidi Henson, Dir., Fin.
- Contact Info
Phone: (858) 768-6500
10931 N. Torrey Pines Rd.
La Jolla, CA 92037
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.